Decreased number of FoxP3+regulatory T cells in preeclampsia

被引:87
作者
Toldi, Gergely [1 ]
Svec, Peter [2 ]
Vasarhelyi, Barna [1 ]
Meszaros, Gergo [1 ]
Rigo, Janos [3 ]
Tulassay, Tivadar [1 ,4 ]
Treszl, Andras [1 ]
机构
[1] Hungarian Acad Sci, Res Grp Pediat & Nephrol, H-1083 Budapest, Hungary
[2] Comenius Univ, Sch Med, Dept Pediat 2, Bratislava, Slovakia
[3] Semmelweis Univ, Dept Obstet & Gynecol 1, H-1085 Budapest, Hungary
[4] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary
关键词
Preeclampsia; regulatory T cell; FoxP3; lymphocyte;
D O I
10.1080/00016340802389470
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Systemic inflammation is characteristic for preeclampsia (PE). A hypothesis for immune dysregulation is that the function of regulatory T cells (CD4+FoxP3+, Tregs) inhibiting the activation of lymphocytes is impaired. We investigated the proportion of Tregs and their cellular network in preeclamptic women. Fifteen preeclamptic and 17 healthy pregnant women were enrolled in the 32nd gestational week (median age 29 (range 22-45) and 32 (range 26-38) years, respectively). PE was diagnosed according to international criteria at a median of 30 gestational weeks (range 21-31). Peripheral blood was taken and blood mononuclear cells were isolated. Flow cytometry was used to determine the proportion of regulatory (CD4+FoxP3+) T cells, lymphoid and myeloid dendritic cells, natural killer and natural killer T cells, naive and memory and activated CD4+ and CD8+cells. The proportion of Tregs and that of naive CD4+CD45RA+ cells was lower in preeclamptic than in control women (p=0.025, p=0.04, respectively). The proportion of other investigated cell types did not differ. Low Treg numbers may support the notion that PE shares similar features to autoimmune disorders. Low Treg numbers are not reflected in the proportion of activated lymphocytes, at least in this stage of pregnancy. This does not exclude, however, the functional alterations of these cell types.
引用
收藏
页码:1229 / 1233
页数:5
相关论文
共 19 条
[1]   Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells [J].
Baecher-Allan, C ;
Wolf, E ;
Hafler, DA .
CLINICAL IMMUNOLOGY, 2005, 115 (01) :10-18
[2]   How do CD4+CD25+ regulatory T cells control autoimmunity? [J].
Bluestone, JA ;
Tang, QZ .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (06) :638-642
[3]   The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) [J].
Brown, MA ;
Lindheimer, MD ;
de Swiet, M ;
Van Assche, A ;
Moutquin, JM .
HYPERTENSION IN PREGNANCY, 2001, 20 (01) :IX-XIV
[4]   FOXP3 modifies the phenotypic and functional properties of regulatory T cells [J].
Campbell, Daniel J. ;
Ziegler, Steven F. .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (04) :305-310
[5]   Activated T lymphocytes in pre-eclampsia [J].
Darmochwal-Kolarz, D. ;
Saito, S. ;
Rolinski, J. ;
Tabarkiewicz, J. ;
Kolarz, B. ;
Leszczynska-Gorzelak, B. ;
Oleszczuk, J. .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2007, 58 (01) :39-45
[6]   Myeloid and lymphoid dendritic cells in normal pregnancy and pre-eclampsia [J].
Darmochwal-Kolarz, D ;
Rolinski, J ;
Tabarkiewicz, J ;
Leszczynska-Gorzelak, B ;
Buczkowski, J ;
Wojas, K ;
Oleszczuk, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (02) :339-344
[7]   CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner [J].
Ghiringhelli, F ;
Ménard, C ;
Terme, M ;
Flament, C ;
Taieb, J ;
Chaput, N ;
Puig, PE ;
Novault, S ;
Escudier, B ;
Vivier, E ;
Lecesne, A ;
Robert, C ;
Blay, JY ;
Bernard, J ;
Caillat-Zucman, S ;
Freitas, A ;
Tursz, T ;
Wagner-Ballon, O ;
Capron, C ;
Vainchencker, W ;
Martin, F ;
Zitvogel, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1075-1085
[8]   Why much of the pathophysiology of preeclampsia-eclampsia has to be autoimmune in nature [J].
Gleicher, Norbert .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (01) :5-6
[9]   Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. [J].
Gupta, Sachin ;
Joshi, Kusum ;
Wig, J. D. ;
Arora, Sunil K. .
ACTA ONCOLOGICA, 2007, 46 (06) :792-797
[10]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061